This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Barrier Therapeutics grosses $46mm with Series B financing
04 Aug 2014
Newly formed Barrier Therapeutics (dermatology drug development; Johnson & Johnson spin-out) grossed $46mm with its Series B round private placement to JP Morgan Partners and TL Ventures, both of which served as lead investors, and to Perseus-Soros BioPharmaceutical Fund, Baker/Tisch Investment Partners, and KBC.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?